Home / Inspections / 1059115

FDA Inspection 1059115 — BioReliance Corporation

BioReliance Corporation — FEI 1122041

The FDA completed an inspection of BioReliance Corporation on July 13, 2018 in Rockville, MD. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 13, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rockville, MD (United States)

Facility

Other inspections at this facility

  • 1295306 (VAI Thu Jan 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1254934 (VAI Fri Nov 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1215040 (NAI Fri Aug 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 983525 (NAI Mon Jan 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 879780 (VAI Wed May 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources